Quick Answer
BIOLARGO, INC. reported Research And Development Expense of $2.59 million for the year ending 2025.
- BIOLARGO, INC. showed a decrease of -10.0% in Research And Development Expense from 2024 to 2025.
- This data is from BIOLARGO, INC.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $17.4 thousand | Q1 2011: $27.2 thousand | Q2 2011: $12.1 thousand | Q3 2011: $9.0 thousand | Q1 2012: $16.3 thousand | Q2 2012: $111.6 thousand | Q3 2012: $122.3 thousand | Q1 2013: $119.2 thousand | Q2 2013: $147.1 thousand | Q3 2013: $267.9 thousand | Q1 2014: $163.6 thousand | Q2 2014: $187.0 thousand | Q3 2014: $187.0 thousand | Q1 2015: $138.0 thousand | Q2 2015: $167.2 thousand | Q3 2015: $162.3 thousand | Q1 2016: $351.1 thousand | Q2 2016: $330.0 thousand | Q3 2016: $348.6 thousand | Q1 2017: $391.3 thousand | Q2 2017: $324.3 thousand | Q3 2017: $425.7 thousand | Q1 2018: $522.0 thousand | Q2 2018: $425.0 thousand | Q3 2018: $442.0 thousand | Q1 2019: $426.0 thousand | Q2 2019: $367.0 thousand | Q3 2019: $332.0 thousand | Q1 2020: $335.0 thousand | Q2 2020: $350.0 thousand | Q3 2020: $347.0 thousand | Q1 2021: $327.0 thousand | Q2 2021: $356.0 thousand | Q3 2021: $344.0 thousand | Q1 2022: $392.0 thousand | Q2 2022: $355.0 thousand | Q3 2022: $271.0 thousand | Q1 2023: $565.0 thousand | Q2 2023: $587.0 thousand | Q3 2023: $694.0 thousand | Q1 2024: $784.0 thousand | Q2 2024: $623.0 thousand | Q3 2024: $690.0 thousand | Q1 2025: $791.0 thousand | Q2 2025: $535.0 thousand | Q3 2025: $615.0 thousand.
- Over the full 16 years of available data (2010 to 2025), BIOLARGO, INC.'s Research And Development Expense has grown by 2,478.5%.
- Historical annual values: Fiscal year 2025: $2.59 million | Fiscal year 2024: $2.88 million | Fiscal year 2023: $2.28 million | Fiscal year 2022: $1.32 million | Fiscal year 2021: $1.37 million | Fiscal year 2020: $1.34 million | Fiscal year 2019: $1.47 million | Fiscal year 2018: $1.72 million | Fiscal year 2017: $1.63 million | Fiscal year 2016: $1.38 million | Fiscal year 2015: $684.6 thousand | Fiscal year 2014: $642.9 thousand | Fiscal year 2013: $742.2 thousand | Fiscal year 2012: $383.5 thousand | Fiscal year 2011: $99.5 thousand | Fiscal year 2010: $100.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: